Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) Sees Significant Decline in Short Interest

Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) was the target of a significant decrease in short interest during the month of September. As of September 30th, there was short interest totalling 8,300 shares, a decrease of 49.7% from the September 15th total of 16,500 shares. Based on an average trading volume of 11,000 shares, the short-interest ratio is currently 0.8 days.

Algernon Pharmaceuticals Stock Performance

Shares of Algernon Pharmaceuticals stock opened at $0.06 on Friday. The stock’s 50-day moving average is $0.07 and its 200 day moving average is $0.08. Algernon Pharmaceuticals has a one year low of $0.04 and a one year high of $0.12.

About Algernon Pharmaceuticals

Algernon Pharmaceuticals Inc operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada and Australia.